Efficacy of lenalidomide plus dexamethasone in patients older than 75 years with relapsed multiple myeloma.

MLA

Touzeau, Cyrille, et al. “Efficacy of Lenalidomide plus Dexamethasone in Patients Older than 75 Years with Relapsed Multiple Myeloma.” Leukemia & Lymphoma, vol. 53, no. 7, July 2012, pp. 1318–20. EBSCOhost, https://doi.org/10.3109/10428194.2011.654116.

APA

Touzeau, C., Blin, N., Clavert, A., Roland, V., Loirat, M., Tessoulin, B., Le Gouill, S., Planche, L., Pennetier, M., Mahe, B., Mohty, M., Malard, F., Peterlin, P., Dubruille, V., & Moreau, P. (2012). Efficacy of lenalidomide plus dexamethasone in patients older than 75 years with relapsed multiple myeloma. Leukemia & Lymphoma, 53(7), 1318–1320. https://doi.org/10.3109/10428194.2011.654116

Chicago

Touzeau, Cyrille, Nicolas Blin, Aline Clavert, Virginie Roland, Marion Loirat, Benoit Tessoulin, Steven Le Gouill, et al. 2012. “Efficacy of Lenalidomide plus Dexamethasone in Patients Older than 75 Years with Relapsed Multiple Myeloma.” Leukemia & Lymphoma 53 (7): 1318–20. doi:10.3109/10428194.2011.654116.